Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer (RTOG 0920) (CIRB)

Conditions

Head and Neck Cancer | Larynx | Lip, Oral Cavity and Pharynx

What is the purpose of this trial?


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Radiation Therapy Oncology Group
Dates:
08/05/2011
Last Updated:
Study HIC#:
1106008671